Abstract:Rationale: Hepatocellular carcinoma (HCC) is primarily characterized by a high incidence of vascular invasion. However, the specific mechanism underlying portal vein tumor thrombus (PVTT) in HCC remains unclear. As a consequence of myeloid cell developmental arrest, CD71+ erythroid progenitor cells (EPCs) and myeloid-derived suppressor cells play important roles in HCC; however, their roles in PVTT remain unclear. Methods: The role of CD71+ EPCs in the HCC tumor microenvironment (TME) was evaluated via morphological, RNA-sequencing, enzyme-linked immunosorbent assay, and flow cytometric analyses. Co-culture techniques were employed to assess the CD45+ EPCs and their vascular compromising effect. Additionally, the PVTT-promoting function of CD45+ EPCs was explored in vivo in a murine model. Results: The CD45+EPCs in HCC tissues exhibited increased myeloid cell features, including morphology, surface markers, transforming growth factor (TGF)-β generation, and gene expression, compared with those in circulation. Hence, a large proportion of CD45+EPCs, particularly those in TMEs, comprise erythroid-transdifferentiated myeloid cells (EDMCs). Additionally, the expression of C-C chemokine receptor type 2 (CCR2) mRNA was upregulated in CD45+EPCs within the TME. Tumor macrophages from HCC tissues induced substantial migration of CD45+EPCs in a dose-dependent manner. Meanwhile, results from immunofluorescence analyses revealed that these two cell types are positively associated in the TME and circulation. That is, EDMCs are chemoattracted by HCC macrophages mainly via CCR2 from CD45+ EPCs in the circulation. Additionally, the expressions of FX, FVII, FGB, C4b, CFB, and CFH were elevated in CD45+EPCs within the TME compared with those in the spleen. The CD45+EPCs from the HCC TME promoted vessel endothelial cell migration and compromised tube formation through TGF-β and FGB, respectively. Additionally, CD45+EPCs from the TME induced HCC cell migration. HCC macrophage-induced CD45+EPCs to exhibit higher levels of FX, FVII, FGB, and TGF-β. Meanwhile, upregulation of CCAAT/enhancer binding protein beta expression induced FGB and TGF-β generation in CD45+EPCs in the TME. WTAP, a major RNA m6A writer, stabilized FX and FVII mRNA and enhanced their nuclear export in CD45+EPCs from the TME. CD45+EPCs from the TME were positively associated with PVTT and poor prognosis. Splenectomy reduced the level of CD45+EPCs in the circulation and TME, as well as the incidence of microvascular invasion. The incidence of microvascular invasion increased following the transfer of HCC tissue CD45+EPCs to splenectomized HCC-bearing mice. Conclusions: The CD45+EPCs enriched in the HCC microenvironment are EDMCs, which are induced by HCC macrophages to migrate from the circulation to the TME. Subsequently, EDMCs promote PVTT by compromising the blood vessel endothelium, aggravating coagulation, and promoting HCC cell migration.

Expression of the Chemokine Receptor CXCR4 in Human Hepatocellular Carcinoma and Its Role in Portal Vein Tumor Thrombus

Significance of Expression of Thrombospondin- 1 and Receptor- CD36 in Hepatocellular Carcinoma

[Expression and Function of ECRG4 in Hepatocellular Carcinoma].

Expression and significance of CCR1 chemokine receptor in human hepatocellular carcinoma

Reduced Expression of Chemokine Receptors on Peripheral Blood Lymphocytes in Patients with Hepatocellular Carcinoma.

TCF12 promotes the tumorigenesis and metastasis of hepatocellular carcinoma via upregulation of CXCR4 expression.

TR4 Nuclear Receptor Suppresses HCC Cell Invasion Via Downregulating the EphA2 Expression

Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances

Ezrin Expression of Hepatocellular Carcinoma and Its Relationship with Adhesion,Invasion and Thrombosis in Portal Vein of Tumor

Increased Expression of Vascular Endothelial Growth Factor-C and Nuclear Cxcr4 in Hepatocellular Carcinoma is Correlated with Lymph Node Metastasis and Poor Outcome

Transcriptomic Analyses of Chemokines Reveal That Down-Regulation of XCR1 is Associated with Advanced Hepatocellular Carcinoma

Role of Chemokine Receptor CXCR4 in Lung Metastasis of Human Hepatocellular Carcinoma

[Nuclear Accumulation of CXCR4 and Overexpressions of VEGF-C and CK19 Are Associated with a Higher Risk of Lymph Node Metastasis in Hepatocellular Carcinoma].

Expression of chemokine receptor CXCR4 in renal cancer patientsand its regulatory mechanisms

[Expression and clinical significance of chemokine CXCL10 and its receptor CXCR3 in hepatocellular carcinoma].

Expression of Platelet-Derived Endothelial Cell Growth Factor and Vascular Endothelial Growth Factor in Hepatocellular Carcinoma and Portal Vein Tumor Thrombus

Erythroid-transdifferentiated myeloid cells promote portal vein tumor thrombus in hepatocellular carcinoma

Desensitization of T Lymphocyte Function by CXCR3 Ligands in Human Hepatocellular Carcinoma

Different Expressions of Chemokine Receptors in Human Hepatocellular Carcinoma Cell Lines with Different Metastatic Potentials

Antitumor Efficacy Of C-X-C Motif Chemokine Ligand 14 In Hepatocellular Carcinoma In Vitro And In Vivo

XCR1: A Promising Prognostic Marker That Pinpoints Targeted and Immune-based Therapy in Hepatocellular Carcinoma